Skip to main content
Some text as placeholder. In real life you can have the elements you have chosen. Like, text, images, lists, etc.
What are you looking for?

Syneos Health Podcast | Investing for Commercial Success as an Emerging Company


When it comes to launching a pharmaceutical product in today’s market—especially as an emerging company—strategic investment can make all the difference.

Drawing from a recent study on investing for commercial success, Michael Sarshad, Managing Director in the Commercial Advisory Group at Syneos Health, discusses the key factors for successfully launching a drug in today's market; the importance of strategic investment, timing and team experience in exceeding launch forecasts; and the diverse areas where this investment is crucial, from medical affairs and market access to clinical strategy and supply chain logistics.

Tune in for expert insights into the intricacies of launching pharmaceutical products and how strategic investment can make all the difference.

For more of our insights on launch and commercialization, check out this content on our Insights Hub:

Investing for Launch Success: The “Goldilocks” Ratio

Investing for Launch Success: Tailoring Your Strategy for Europe

Good Science Is Not Good Enough: For Emerging Companies, Differentiation Requires a Commercial Value Creation Story

Supporting the Launch of Biosimilars

WEBINAR | The Three Perils of Cross-Functional Commercialization: Time, Insight and Integration

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

Jeff Stewart
Michael Sarshad

Interested in Syneos Health?